Optimized Vaccine Development and Manufacturing: A Technology Overview - Certain technology solutions can greatly improve the vaccine manufacturing process. - BioPharm International

ADVERTISEMENT

Optimized Vaccine Development and Manufacturing: A Technology Overview
Certain technology solutions can greatly improve the vaccine manufacturing process.


BioPharm International


19. Kaludov N, et al. Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography. Human Gene Therapy. 2002;13(10):1235–43.

20. Kalbfuss B. et al. Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography. Biotechnol Bioeng. 2007;96(5):932–944.

21. Novais JL, Titchener-Hooker NJ, Hoare M. Economic comparison between conventional and disposables-based technology for the production of biopharmaceuticals. Biotechnol and Bioengi. 2001;75(2):143–153.

22. Gen Engi news. 2004;24(8).

23. 3rd Annual Report and Survey of Biopharmaceutical Manufacturing, Capacity and Production.

24. Sinclair A, Monge M. Biomanufacturing for the 21st Century: Designing a concept facility based on single-use systems. BioProcess Int. 2004 Oct supp:26–31.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here